12 | Type I DNA Topoisomerases (Topoisomerase I)IBA
04/2024
-
01/2002 |
8 | Topoisomerase I InhibitorsIBA
01/2018
-
12/2003 |
6 | Anti-Bacterial Agents (Antibiotics)IBA
01/2022
-
03/2005 |
6 | EnzymesIBA
01/2017
-
11/2004 |
6 | Aromatase (CYP19)IBA
01/2016
-
07/2010 |
6 | 6,7-dimethyl-8-ribityllumazine synthase (lumazine synthase)IBA
05/2010
-
03/2005 |
6 | CamptothecinIBA
08/2008
-
12/2003 |
6 | NucleosidesIBA
04/2008
-
09/2005 |
5 | Estrogen ReceptorsIBA
12/2021
-
03/2004 |
5 | Proteins (Proteins, Gene)FDA Link
05/2020
-
02/2005 |
5 | Aromatase InhibitorsIBA
11/2016
-
06/2007 |
4 | DNA (Deoxyribonucleic Acid)IBA
12/2021
-
01/2012 |
4 | TubulinIBA
10/2004
-
10/2002 |
3 | PoisonsIBA
12/2019
-
12/2012 |
3 | LactamsIBA
01/2017
-
05/2007 |
3 | Selective Estrogen Receptor Modulators (SERM)IBA
11/2016
-
03/2015 |
3 | ResveratrolIBA
09/2015
-
03/2004 |
3 | Antineoplastic Agents (Antineoplastics)IBA
03/2015
-
07/2003 |
3 | NSC 724998IBA
12/2012
-
11/2007 |
3 | isoquinolineIBA
06/2012
-
07/2005 |
3 | Retinoid X Receptors (Retinoid X Receptor)IBA
06/2012
-
04/2011 |
3 | Reverse Transcriptase InhibitorsIBA
04/2008
-
04/2006 |
3 | 2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2007
-
11/2003 |
2 | Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
12/2021
-
02/2008 |
2 | indimitecanIBA
01/2018
-
12/2012 |
2 | Topotecan (Hycamtin)FDA LinkGeneric
01/2018
-
01/2018 |
2 | tyrosyl-DNA phosphodiesteraseIBA
01/2017
-
05/2014 |
2 | TamoxifenFDA LinkGeneric
01/2016
-
05/2012 |
2 | Estrogens (Estrogen)FDA Link
01/2016
-
03/2004 |
2 | ProdrugsIBA
01/2016
-
06/2005 |
2 | Acetates (Acetic Acid Esters)FDA Link
09/2015
-
11/2008 |
2 | 3- amino- 6- (3- aminopropyl)- 5,6- dihydro- 5,11- dioxo- 11H- indeno(1,2- c)isoquinolineIBA
03/2012
-
04/2011 |
2 | Riboflavin SynthaseIBA
08/2009
-
09/2007 |
2 | zapotinIBA
11/2008
-
01/2007 |
2 | Antiviral Agents (Antivirals)IBA
08/2008
-
04/2008 |
2 | Human immunodeficiency virus 1 reverse transcriptaseIBA
02/2008
-
09/2005 |
2 | 6- (3- (2- hydroxyethyl)amino- 1- propyl)- 5,6- dihydro- 2,3- dimethoxy- 8,9- methylenedioxy- 5,11- dioxo- 11H- indeno(1,2- )isoquinolineIBA
02/2005
-
11/2003 |
2 | 2-MethoxyestradiolIBA
10/2004
-
10/2002 |
2 | lavendustin AIBA
04/2003
-
10/2002 |
1 | Type II DNA Topoisomerases (Topoisomerase II)IBA
12/2021 |
1 | Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2021 |
1 | Gatifloxacin (Zymar)FDA Link
05/2020 |
1 | FluoroquinolonesIBA
05/2020 |
1 | Ciprofloxacin (Cipro)FDA LinkGeneric
05/2020 |
1 | Azithromycin (Zithromax)FDA LinkGeneric
05/2020 |
1 | MacrolidesIBA
05/2020 |
1 | tofacitinibIBA
12/2018 |
1 | Antiparasitic Agents (Antiparasitics)IBA
11/2018 |
1 | Histones (Histone)IBA
01/2018 |
1 | Therapeutic UsesIBA
01/2018 |
1 | Estradiol (Delestrogen)FDA LinkGeneric
01/2016 |
1 | triphenylethyleneIBA
01/2016 |
1 | NitrogenIBA
01/2016 |
1 | Epidermal Growth Factor (EGF)IBA
09/2015 |
1 | CaspasesIBA
09/2015 |
1 | Serine (L-Serine)FDA Link
09/2015 |
1 | Cyclin D1IBA
09/2015 |
1 | Sirolimus (Rapamycin)FDA Link
09/2015 |
1 | SurvivinIBA
09/2015 |
1 | Tyrosine (L-Tyrosine)FDA Link
09/2015 |
1 | Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2015 |
1 | Cyclin B1IBA
09/2015 |
1 | FluorineIBA
05/2015 |
1 | ChlorineIBA
05/2015 |
1 | AntigensIBA
04/2015 |
1 | Mupirocin (Bactroban)FDA LinkGeneric
01/2015 |
1 | ThiazolesIBA
01/2015 |
1 | Methicillin (Metin)FDA Link
02/2014 |
1 | 7-azaindenoisoquinolineIBA
02/2014 |
1 | Hormones (Hormone)IBA
09/2013 |
1 | N,N-didesmethyl-4-hydroxytamoxifenIBA
06/2013 |
1 | semiquinone radicalsIBA
12/2012 |
1 | Free Radical ScavengersIBA
12/2012 |